NAD+ Therapy Benefits: Clinical Evidence & Results
Medically reviewed by the Vea Health Clinical Team
TL;DR: NAD+ therapy benefits range from enhanced cellular energy to improved metabolic function. A 2018 study in Nature Communications found nicotinamide riboside supplementation significantly elevated NAD+ levels in healthy middle-aged and older adults, with excellent tolerability profiles across diverse patient populations [Martens, 2018].
Your cells depend on NAD+ for energy production, DNA repair, and hundreds of other critical functions. But here's the challenge: NAD+ levels decline significantly with age, dropping by as much as 50% between your 40s and 60s.
NAD+ therapy benefits have emerged as a focal point in evidence-based approaches to aging and metabolic health. This naturally occurring molecule plays a central role in how your body converts food into energy, maintains healthy cells, and supports resilience against age-related decline.
What Is NAD+ and Why Does It Matter?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell of your body. It acts as a critical helper molecule for mitochondria, the power plants of your cells. According to a 2020 systematic review in Experimental Gerontology, NAD+ serves as an essential cofactor for energy production, DNA repair, gene expression, and cellular signaling processes that determine how well your body functions as you age [Braidy, 2020].
Think of NAD+ as fuel for your cellular machinery. Without adequate levels, your cells struggle to produce energy efficiently. They also have a harder time repairing DNA damage and responding to stress.
Your NAD+ levels aren't static. They decline progressively with age, contributing to many changes people associate with getting older. This decline affects virtually every organ system, from your brain and heart to your muscles and skin.
How Does NAD+ Therapy Work?
NAD+ therapy involves supplementation with NAD+ precursors, molecules your body converts into active NAD+. The most researched precursors include nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Research indicates these compounds can effectively raise NAD+ levels when taken orally, offering a practical approach to addressing age-related NAD+ decline.
Your body has multiple pathways to produce NAD+. The salvage pathway recycles existing NAD+ breakdown products, while the de novo pathway creates NAD+ from scratch using dietary tryptophan. Supplementing with precursors supports these natural pathways.
A 2018 randomized controlled trial published in Nature Communications demonstrated that chronic nicotinamide riboside supplementation was well-tolerated and significantly elevated NAD+ levels in healthy middle-aged and older adults [Martens, 2018]. Patients in the study showed measurable increases in NAD+ bioavailability without adverse effects.
What Are the Key Benefits of NAD+ Therapy?
Clinical studies suggest NAD+ therapy may support improvements across multiple body systems. A 2024 meta-analysis in Current Diabetes Reports examined eight randomized controlled trials and found that NMN supplementation at dosages ranging from 250-2000 mg daily showed effects on markers of glucose and lipid metabolism [Chen, 2024]. The evidence base continues to grow as more physician-led protocols incorporate NAD+ precursors.
Energy and Cellular Function
Patients have reported noticeable improvements in energy levels and physical stamina. NAD+ directly participates in the cellular respiration process that converts nutrients into usable energy. When NAD+ levels increase, mitochondrial function often improves.
A 2024 study in Nature Communications examined nicotinamide riboside for peripheral artery disease. Researchers found that oral NR increases bioavailability of NAD+, which reduces oxidative stress and serves as an essential cofactor for mitochondrial respiration [McDermott, 2024].
Metabolic Health Support
Research indicates potential benefits for blood sugar management and fat metabolism. Your body uses NAD+ for enzymes involved in processing glucose and lipids. Better NAD+ availability may support healthier metabolic function.
According to a 2025 meta-analysis in Critical Reviews in Food Science and Nutrition, NMN supplementation showed effects on fasting glucose, triglycerides, and cholesterol markers in randomized controlled trials [Zhang, 2025]. Individual responses varied, but the overall pattern suggested metabolic support.
Cognitive and Neurological Support
Evidence supports the use of NAD+ precursors for brain health applications. A 2024 systematic review in the Journal of Alzheimer's Disease noted that maintenance of intracellular NAD+ levels represents a promising therapeutic strategy, with NAD+ precursors showing potential for supporting cognitive function [Alghamdi, 2024].
Brain cells are particularly energy-demanding. They require substantial NAD+ to maintain normal function, protect against oxidative stress, and support the repair mechanisms that keep neurons healthy.
Physical Performance and Recovery
Many patients begin noticing changes in exercise recovery and physical resilience within weeks of starting their protocol. NAD+ plays a role in muscle cell energy production and the cellular stress response that follows physical activity.
A 2024 study on long-term nicotinamide riboside use found improvements in coordination and eye movements in patients with ataxia telangiectasia, suggesting neurological benefits from sustained NAD+ support [Presterud, 2024].
"NAD+ acts as an important cofactor and substrate for a multitude of biological processes including energy production, DNA repair, gene expression, and calcium-dependent secondary messenger signaling." , Braidy & Liu, Experimental Gerontology, 2020
Who Should Consider NAD+ Therapy?
Adults over 30 experiencing age-related changes in energy, recovery, or metabolic health may benefit from NAD+ support. Clinical experience shows particular interest from patients focused on proactive health optimization rather than waiting for significant decline. Your individual health status, goals, and medical history determine whether NAD+ therapy aligns with your needs.
NAD+ therapy isn't exclusively for older adults. Younger individuals with high physical demands, metabolic concerns, or specific health goals sometimes explore NAD+ protocols as part of comprehensive wellness strategies.
At Vea Health, our physician-led approach means your protocol gets personalized based on your complete health picture. We consider your symptoms, laboratory values, lifestyle factors, and treatment objectives to determine if NAD+ supplementation fits your journey.
Common Candidates for NAD+ Protocols
Adults 40+ noticing declining energy or slower recovery from exercise
Individuals with metabolic health goals related to blood sugar or weight management
Patients interested in evidence-based anti-aging protocols supported by peer-reviewed research
People seeking to optimize cognitive function and mental clarity
Those with family histories of age-related metabolic or neurological conditions
What Does the Research Show About Safety?
Multiple randomized controlled trials have demonstrated favorable safety profiles for NAD+ precursors at therapeutic dosages. The 2018 Nature Communications study found chronic nicotinamide riboside supplementation was well-tolerated in middle-aged and older adults with no significant adverse events reported [Martens, 2018]. Studies have examined dosages ranging from 250 mg to 2000 mg daily across durations from several weeks to extended periods.
Common reported effects include mild digestive changes during the initial adjustment period. These typically resolve within days as your body adapts to the supplement. Serious adverse events remain rare in clinical literature.
That said, individual responses vary. Your unique physiology, existing health conditions, and concurrent medications all influence how you respond to NAD+ therapy. This is why physician oversight matters.
The Personalized Protocol Approach
Evidence-based NAD+ therapy starts with understanding your baseline. Many patients begin noticing changes around the 2-4 week mark, though timelines differ. Some report shifts in energy within days, while metabolic markers may take longer to respond.
Your protocol may include dosage adjustments based on your response and lab values. This personalized approach helps optimize benefits while minimizing any unwanted effects. It's not one-size-fits-all.
How Does NAD+ Fit Into a Comprehensive Wellness Strategy?
NAD+ therapy works best as part of a broader health optimization plan. While supplementation can raise NAD+ levels, lifestyle factors also influence how your body produces and uses this critical molecule. Sleep quality, exercise patterns, nutritional choices, and stress management all affect NAD+ metabolism.
Clinical evidence suggests combining NAD+ precursors with other supportive interventions may enhance outcomes. A 2021 randomized controlled trial examined CoQ10 plus NADH supplementation in patients with chronic fatigue syndrome, finding improvements in fatigue perception and quality of life measures [Castro-Marrero, 2021].
Many patients integrate NAD+ support alongside other evidence-based approaches. This might include optimizing hormone levels, addressing nutrient deficiencies, or refining exercise and recovery protocols. The synergy between interventions often exceeds what any single approach delivers alone.
Ready to explore your options?
Our clinical team can help you determine whether NAD+ therapy aligns with your health goals. We'll review your history, discuss the evidence, and create a personalized protocol designed for your unique needs.
Frequently Asked Questions
How long does it take to see NAD+ therapy benefits?
Many patients begin noticing changes in energy and recovery within 2-4 weeks of consistent use, according to clinical observations. Metabolic markers may take 8-12 weeks to show measurable shifts. Individual timelines vary based on baseline NAD+ levels, dosage, and overall health status.
What's the difference between NR and NMN?
Both nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are NAD+ precursors that your body converts into active NAD+. NR has more extensive human clinical trial data, while NMN research is growing. Both have demonstrated the ability to raise NAD+ levels, with choice often depending on individual response and protocol design.
Can NAD+ therapy help with weight management?
Research indicates NAD+ precursors may support metabolic health markers related to weight management. A 2024 meta-analysis found NMN supplementation affected glucose and lipid metabolism in randomized trials [Chen, 2024]. NAD+ therapy works best as part of comprehensive lifestyle approaches rather than as a standalone intervention.
Are there any side effects of NAD+ supplementation?
Clinical trials have shown excellent tolerability for NAD+ precursors at therapeutic dosages. The most commonly reported effects are mild digestive changes during the initial adjustment period. Serious adverse events are rare in published studies. Your physician can monitor your response and adjust your protocol as needed.
How is NAD+ therapy different from IV NAD+?
Oral NAD+ precursors (NR and NMN) have been more extensively studied in randomized controlled trials than direct IV NAD+ administration. Oral precursors work with your body's natural pathways to raise NAD+ levels sustainably. Both approaches aim to increase NAD+ bioavailability, but oral supplementation offers convenience for daily, consistent use.
References
Martens C, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018. PMID: 29599478
Castro-Marrero J, et al. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021. PMID: 34444817
McDermott M, et al. Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature Communications. 2024. PMID: 38871717
Alghamdi M, Braidy N. Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach. Journal of Alzheimer's Disease. 2024. PMID: 39422945
Braidy N, Liu Y. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Experimental Gerontology. 2020. PMID: 31917996
Chen F, et al. Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Current Diabetes Reports. 2024. PMID: 39531138
Presterud R, et al. Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia. Movement Disorders. 2024. PMID: 37899683
Zhang J, et al. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Critical Reviews in Food Science and Nutrition. 2025. PMID: 39116016
Learn more about your options:
Source Studies:
Landiolol for heart rate control in patients with septic shock and persistent ta... — Intensive care medicine (2024)
Are manual therapies, passive physical modalities, or acupuncture effective for ... — The spine journal : official journal of the North American Spine Society (2016)
Chronic nicotinamide riboside supplementation is well-tolerated and elevate... — Nature communications (2018)
Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality.
Treatments are prescribed at provider discretion. Individual results may vary.